Rezolute, Inc. (RZLT)
3.325
+0.02
(+0.76%)
USD |
NASDAQ |
May 27, 16:00
3.325
0.00 (0.00%)
After-Hours: 16:47
Rezolute Cash from Investing (Quarterly) : 12.28M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| XOMA Royalty Corp. | 6.552M |
| SELLAS Life Sciences Group, Inc. | 0.00 |
| ADMA Biologics, Inc. | 2.404M |
| Krystal Biotech, Inc. | -63.58M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.74M |
| Cash from Financing (Quarterly) | 0.747M |
| Free Cash Flow | -73.48M |
| Free Cash Flow Per Share (Quarterly) | -0.132 |
| Free Cash Flow to Equity (Quarterly) | -13.56M |
| Free Cash Flow to Firm (Quarterly) | -13.74M |
| Free Cash Flow Yield | -21.80% |